CNBX Pharmaceuticals Inc. SEC filings CNBX
CNBX Pharmaceuticals Inc. has 301 filings in SEC EDGAR's recent list, going back to Jan 9, 2006. Its latest annual report, Form 10-K, was filed on Dec 1, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jun 24, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (auditor change). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Mar 6, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Mar 27, 2019 | — |
| 3 | Initial insider ownership | Feb 4, 2019 | Dec 31, 2018 |
| 144 | Notice of proposed sale | Dec 21, 2016 | — |
| 4 | Insider transaction | Jul 24, 2014 | Jul 25, 2014 |
| 4 | Insider transaction | Jul 11, 2014 | Jun 23, 2014 |
| 4 | Insider transaction | Jun 25, 2014 | May 8, 2014 |
| SC 13D | Ownership over 5% (active) | Jun 25, 2014 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jun 25, 2014 | — |
| 4/A | Primary document | Jun 24, 2014 | May 8, 2014 |
| SC 13D/A | Amended ownership over 5% (active) | May 1, 2014 | — |
| 4 | Insider transaction | Apr 30, 2014 | Apr 25, 2014 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 25, 2013 | — |
| 4/A | Primary document | Nov 4, 2013 | Oct 28, 2013 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 4, 2013 | — |
| SC 13D | Ownership over 5% (active) | Oct 29, 2013 | — |
| 4 | Insider transaction | Oct 28, 2013 | Oct 28, 2013 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 3, 2013 | — |
| 4/A | Primary document | Jul 2, 2013 | Jun 24, 2013 |
| 4 | Insider transaction | Jun 28, 2013 | Jun 24, 2013 |
| SC 13D | Ownership over 5% (active) | Jun 28, 2013 | — |
| 4 | Insider transaction | Nov 14, 2011 | Nov 8, 2011 |
| SC 13D | Ownership over 5% (active) | Jun 29, 2011 | — |
| 3 | Initial insider ownership | Jun 28, 2011 | May 31, 2011 |
| 4 | Insider transaction | Sep 26, 2007 | Sep 25, 2007 |
| 4 | Insider transaction | Sep 26, 2007 | Sep 25, 2007 |
| SC 13D | Ownership over 5% (active) | Sep 26, 2007 | — |
| 3 | Initial insider ownership | Apr 13, 2006 | Apr 13, 2006 |
| 3 | Initial insider ownership | Apr 12, 2006 | Apr 12, 2006 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNBX (OTC)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Bethesda, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1343009
- Former names
- Cannabics Pharmaceuticals Inc. (until Mar 16, 2022); American Mining Corp (until May 1, 2014); Thrust Energy Corp. (until May 10, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.